FDA
Aspruzyo Sprinkle
The FDA lists this product in 2 strengths and forms.
Composition
- Active ingredients
- RANOLAZINE 1GM
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RANOLAZINE 500MG · Granule, extended releaseNDA216018-001 · Discontinued
- RANOLAZINE 1GM · Granule, extended releaseThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA216018.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Aspruzyo Sprinkle
- Active substance
- ranolazine
- Route
- Oral
- Dosage form
- Granule, extended release
- Applicant
- Spil
- Status
- Discontinued
- FDA approval
- 28 Feb 2022
- Application
- NDA216018-002